Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dr. Reddy’s and its subsidiary, Promius Pharma announced the filing of NDA for its migraine candidate DFN-02 with the FDA.
read more
Accelovance has signed a merger agreement with Linical, a CRO based in Asia in the fields of oncology, immunology, and neurology.
read more
Evotec has launched its accelerated drug development service INDiGO.
read more
Advarra announces its leadership structure.
read more
Charles River Laboratories has completed the previously announced acquisition of MPI Research for approximately $800 million in cash, subject to certain customary adjustments.
read more
Sekisui XenoTech now offers human liver tissue microarrays and a microsomal pool for studying and developing new treatments for fatty liver disease.
read more
Avara Pharmaceutical announced the acquisition of the GlaxoSmithKline consumer healthcare manufacturing facility in Aiken, South Carolina is complete.
read more
Wednesday, April 04, 2018
Paul R. Carter and Anne C. Whitaker have experience in the branded pharmaceutical industry and will join the Mallinckrodt Board pending shareholder vote at the Annual General Meeting in May, 2018.
read more
Wednesday, April 04, 2018
Albemarle announced the completion of the previously announced sale of its polyolefin catalysts and components business to W. R. Grace & Co. in a cash transaction valued at approximately $416 million.
read more
Wednesday, April 04, 2018
GSL Biotech and VectorBuilder have formed a partnership to create a complete cloning solution, allowing customers to order their entire custom plasmids directly from VectorBuilder through GSL Biotech’s “SnapGene” software.
read more
Wednesday, April 04, 2018
Effective immediately, the company’s board of directors promoted Robert G. Kramer Sr. to the newly-created position of president and COO, and appointed Richard S. Lindahl as the company’s new executive vice president and CFO.
read more
Ortho Clinical Diagnostics announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
read more
HCL Technologies Limited announced the acquisition of C3i Solutions, a multi-channel customer engagement services for the life sciences and consumer packaged goods (CPG) industries, from Merck.
read more
Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.
read more
Celltrion received CRLs from the FDA regarding the BLA for CT-P10, a proposed biosimilar to Rituxan and CT-P6, a proposed biosimilar to Herceptin.
read more